Buti, M. Et Al. 2015. Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. HEPATOLOGY INTERNATIONAL , vol.9, no.2 , 243-250.

Buti, M., Fung, S., Gane, E., Afdhal, N. H., Flisiak, R., GÜREL, S., ... Flaherty, J. F.(2015). Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. HEPATOLOGY INTERNATIONAL , vol.9, no.2, 243-250.

Buti, Maria Et Al. "Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years," HEPATOLOGY INTERNATIONAL , vol.9, no.2, 243-250, 2015

Buti, Maria Et Al. "Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years." HEPATOLOGY INTERNATIONAL , vol.9, no.2, pp.243-250, 2015

Buti, M. Et Al. (2015) . "Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years." HEPATOLOGY INTERNATIONAL , vol.9, no.2, pp.243-250.

@article{article, author={Maria Buti Et Al. }, title={Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years}, journal={HEPATOLOGY INTERNATIONAL}, year=2015, pages={243-250} }